Other Information.
+Added: 1 to Exclusive License Agreement between The Cleveland Clinic Foundation and Anixa Biosciences, Inc.
+Added: (Certain information has
+Added: been redacted in the marked portions of the exhibit.)
Certification
−Removed: of Chief Executive Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, dated June 10, 2022.
+Added: of Chief Executive Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, dated September 9, 2022.
Certification
−Removed: of Chief Financial Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, dated June 10, 2022.
−Removed: of Chief Executive Officer, pursuant to Section 1350 of Title 18 of the United States Code, dated June 10, 2022.
−Removed: of Chief Financial Officer, pursuant to Section 1350 of Title 18 of the United States Code, dated June 10, 2022.
+Added: of Chief Financial Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, dated September 9, 2022.
+Added: of Chief Executive Officer, pursuant to Section 1350 of Title 18 of the United States Code, dated September 9, 2022.
+Added: of Chief Financial Officer, pursuant to Section 1350 of Title 18 of the United States Code, dated September 9, 2022.
Inline XBRL Instance Document
4 unchanged sentences
Inline XBRL Taxonomy Extension Presentation Linkbase
−Removed: Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101)
+Added: Cover Page Interactive Data File (formatted in Inline
+Added: XBRL and contained in Exhibit 101)
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by
5 unchanged sentences
Financial Officer
−Removed: Financial and Accounting Officer)
+Added: Financial and
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.